Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
White Paper
Disaster Recovery and Work Comp
Careful planning can blunt nature’s impact on workers’ compensationIn just the past few years, natural disasters have generated startling
Mitchell
News Release
Mitchell’s Tina Greene Elected to Cooperative Exchange, The National Clearinghouse Association Board
Mitchell Regulatory and Industry Relations Director Tina Greene was elected to serve on the
Workers' Comp
Blog
My Way, Right Now
Workers' Comp
Podcast
Chronicling the World of Workers’ Comp with Roberto Ceniceros
Last month, workers’ compensation lost one of its most talented reporters and influencers as Roberto Ceniceros announced his retirement.
Workers' Comp
Article
Gabapentinoids in Workers’ Compensation
Nearly 20 percent o
Workers' Comp
Blog
Destination Care
Destination care, centers of excellence, medical tourism, benefit driven travel and geographically recognized care centers – mean what exactl